arrow
G

Giovanni Esposito

university of naples federico ii
H指数:77
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Myocardial function recovery in peripartum cardiomyopathy: the role of global longitudinal strain and myocardial work

围产期心肌病中心肌功能恢复:整体纵向应变和心肌做功的作用

2026-09-010
OA
Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII study

替格瑞洛在行经皮冠状动脉介入治疗的ST段抬高型心肌梗死或非ST段抬高型心肌梗死患者中的药效学效应:POMPEII研究的启示

2026-04-150
OAAI
Optimal Medical Therapy Targeting Metabolic Status for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention
2026-01-310
OAAI
Predicting Exercise Pulmonary Hypertension: The RIGHT-NET Machine Learning model A Pilot Study

预测运动性肺动脉高压:RIGHT-NET机器学习模型——一项初步研究

2025-12-300
OAAI
Anatomical and intraoperative predictors of surgical complications after distal hypospadias repair with foreskin reconstruction: a prospective study

远端尿道下裂修复伴包皮重建术后手术并发症的解剖学及术中预测因素:一项前瞻性研究

2025-12-040
OAAI
Physiology vs angiography-guided percutaneous coronary intervention in transcatheter aortic valve implantation: the FAITAVI trial

生理学 vs 血管造影引导的经皮冠状动脉介入治疗在经导管主动脉瓣植入术中的应用:FAITAVI 研究

2025-12-011
PRE
Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention

针对接受经皮冠状动脉介入治疗患者的二级预防,以脂质和炎症为目标的最佳药物治疗

2025-11-240
OAAI
Clinical Impact of In-Hospital Hemoglobin Decline Without Overt Bleeding After Transcatheter Aortic Valve Replacement

经导管主动脉瓣置换术后院内血红蛋白下降而无显性出血的临床影响

2025-11-240
PRE
Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: Design of the AMUNDSEN Trial

瑞莫尤单抗在经皮冠状动脉介入治疗急性心肌梗死前的应用:AMUNDSEN试验设计

2025-11-030
OAAI
Sex differences among elderly ACS patients undergoing percutaneous coronary intervention receiving Ticagrelor 60 mg vs. 90 mg

老年ACS患者接受经皮冠状动脉介入治疗时,Ticagrelor 60 mg与90 mg的性别差异

2025-11-010
OA